Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Diagnosis and Treatment of Idiopathic Overactive Bladder: AUA/SUFU Guideline (2024)
Using AUA Guidelines
Access to AUA guidelines is provided free for individuals’ clinical use only. Anyone accessing AUA guidelines for any other purpose must obtain a license in advance. Licenses for academic, research and educational purposes can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to, and limited authorized use of AUA guidelines is a member benefit. Members are granted a limited license to access and use the AUA Guidelines for their individual, non-commercial use, for clinical, academic, educational, and research purposes, in accordance with the AUA Guidelines Terms and Conditions of Use. Members who wish to use the Guidelines for any other purpose, or in any manner not authorized by this limited license grant or by the AUA Guidelines Terms and Conditions of Use must request and obtain a license/permission in advance. Licenses for business or institutional academic, research and educational related purposes (e.g., use in course packs or for employer-sponsored research) can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to AUA guidelines is provided free for individual clinical use only, in accordance with the AUA Guidelines Terms and Conditions of Use. Anyone accessing AUA guidelines for any other purpose must obtain a license/permission in advance. Licenses for academic, research and educational purposes (e.g., in course packs or employer-sponsored research) can be requested through the AUA by contacting permissions@AUAnet.org.
Licenses for promotional or commercial use can be requested by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on AUA clinical guideline usage and licensing.
By reading this guideline, you agree to AUA's Guidelines Terms and Conditions of Use.
Using AUA Guidelines
Access to AUA guidelines is provided free for health care providers for their individual clinical use only. Patients and the general public are provided a summary of the guidelines. Patients who wish to discuss the full guidelines should consult with their healthcare provider.
Guideline Resources
Urology A-Z Overactive Bladder Web Article
Unabridged PDF for this Guideline
Algorithm for this Guideline
The Journal of Urology® Article
Purpose
Overactive bladder (OAB) is defined by the International Continence Society (ICS) as “urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence (UUI), in the absence of urinary tract infection (UTI) or other obvious pathology.” The prevalence of OAB and its impact on quality of life (QoL) across the life span is significant. Patients with OAB present to several types of providers including primary care, specialty care, physical therapists, and alternative medicine providers. The purpose of this OAB guideline is to provide evidence-based guidance to all types of clinicians and patients regarding the evaluation, management, and treatment of idiopathic OAB.
Key Takeaways
The guideline informs the reader on valid diagnostic processes and provides an approach to maximizing symptom control and patient QoL through shared decision-making, while minimizing adverse events and burden of disease. The strategies and approaches recommended in this document were derived from evidence-based and consensus-based methods. The clinical guideline includes discussion of the following:
- Diagnosis and evaluation
- Non-invasive therapies
- Pharmacology
- Minimally invasive procedures
- Invasive therapies
- Indwelling catheters
- OAB and BPH
Create a free account to access expanded content and resources.
AUA Clinical Practice Guidelines are developed by multidisciplinary panels of experts based on rigorous systematic review of current urologic research.
| Free Resources | |
|
Urology A-Z Overactive Bladder Web Article |
| Login to Continue | |
|
Urology A-Z Overactive Bladder Web Article |
| Member Benefit | |
|
Unabridged PDF for this Guideline |
|
Algorithm for this Guideline |
|
The Journal of Urology® Article |